Mainsail Financial Group’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$402K Sell
14,091
-147
-1% -$3.91K 0.14% 60
2026
Q2
$343K Buy
14,238
+147
+1% +$3.84K 0.12% 63
2026
Q1
$396K Hold
14,091
– – 0.16% 54
2025
Q4
$351K Buy
14,091
+5,055
+56% +$127K 0.15% 54
2025
Q3
$230K Sell
9,036
-4,293
-32% -$106K 0.1% 60
2025
Q2
$328K Buy
+13,329
New +$311K 0.15% 53

Other funds holding PFE

Mainsail Financial Group's PFE Position: Q3 2026 in Review

Mainsail Financial Group reduced its Pfizer (PFE) stake by 1% in Q3 2026, selling an estimated $3.91K and leaving 14,091 shares worth $402K. The position accounts for 0.14% of the portfolio, ranked #60.

Mainsail Financial Group first reported a position in PFE in Q2 2025 and has held it in 6 quarters since. 2,915 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • Mainsail Financial Group held 14,091 shares of Pfizer worth $402K as of Q3 2026.
  • Mainsail Financial Group sold 147 Pfizer shares in Q3 2026, an estimated $3.91K.
  • Pfizer made up 0.14% of Mainsail Financial Group's portfolio in Q3 2026, its #60 holding.
  • Mainsail Financial Group first reported a position in Pfizer in Q2 2025 and has held it in 6 quarters since.
  • 2,915 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on Mainsail Financial Group's 13F filing for Q3 2026, filed 23 Oct 2026.